Literature DB >> 6405507

The effects of saccharin on the metabolism of dietary tryptophan to indole, a known cocarcinogen for the urinary bladder of the rat.

J Sims, A G Renwick.   

Abstract

Adult male rats were fed diets containing 0 to 10% saccharin, 2% tryptophan, or 2% tryptophan plus 5% saccharin ad libitum for 1 to 2 months. Saccharin produced a dose-related increase in the urinary excretion of indican which is the main metabolite of indole. The renal clearances of both indican and saccharin were reduced at high plasma concentrations (200 to 300 micrograms/ml) of saccharin, suggesting saturation of renal tubular secretion. The increased amounts of indican in the urine, and of indole in the cecum arose from accumulation of protein and tryptophan in the cecum rather than an increase in the enzyme tryptophanase which metabolizes tryptophan to indole. The high levels of protein in the ceca of rats fed saccharin-containing diets were associated with a dose-related increase in the weight of the contents and wall of the cecum. Administration of 2% tryptophan in the diet increased significantly the amounts of tryptophan in the cecum and in plasma, but produced only small increases in the size of the cecum, the amount of indole present, and the excretion of indican. The effects of saccharin and tryptophan were additive. These effects are consistent with saccharin having a major effect on protein digestion in the intestine such that increased amounts of tryptophan are available in the cecum for microbial metabolism to indole. The greater formation of indole and excretion of indican in the urine suggest that saccharin increases the catabolism of dietary tryptophan to metabolites with known cocarcinogenic activity toward the rat bladder.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405507     DOI: 10.1016/0041-008x(83)90252-1

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate.

Authors:  E Banoglu; G G Jha; R S King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

Review 2.  Are there acyl-homoserine lactones within mammalian intestines?

Authors:  Matthew C Swearingen; Anice Sabag-Daigle; Brian M M Ahmer
Journal:  J Bacteriol       Date:  2012-11-09       Impact factor: 3.490

3.  Artificial sweeteners are not drugs: where does that leave us?

Authors:  C J Baines
Journal:  Can Med Assoc J       Date:  1984-12-15       Impact factor: 8.262

4.  The acyl homoserine lactone receptor, SdiA, of Escherichia coli and Salmonella enterica serovar Typhimurium does not respond to indole.

Authors:  Anice Sabag-Daigle; Jitesh A Soares; Jenée N Smith; Mohamed E Elmasry; Brian M M Ahmer
Journal:  Appl Environ Microbiol       Date:  2012-05-18       Impact factor: 4.792

Review 5.  Indole: a signaling molecule or a mere metabolic byproduct that alters bacterial physiology at a high concentration?

Authors:  Jisun Kim; Woojun Park
Journal:  J Microbiol       Date:  2015-06-27       Impact factor: 3.422

6.  Depressive symptoms, fruit and vegetables consumption and urinary 3-indoxylsulfate concentration: a nested case-control study in the French Nutrinet-Sante cohort.

Authors:  Emmanuelle Kesse-Guyot; Pilar Galan; Fabien Szabo de Edelenyi; Catherine Philippe; Nathalie Druesne-Pecollo; Laurent Naudon; Sylvie Rabot; Serge Hercberg; Paule Latino-Martel
Journal:  Eur J Nutr       Date:  2020-06-25       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.